Open AccessP088 (0136) BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH HIGH‐RISK ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA (CHL): RESULTS OF PRESPECIFIED SUB‐GROUP ANALYSES FROM THE ECHELON‐1 STUDY
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547931.94329.07
Subject(s) - brentuximab vedotin , classical hodgkin lymphoma , stage (stratigraphy) , medicine , oncology , lymphoma , hodgkin lymphoma , chemotherapy , biology , paleontology